1.024

0.39% 0.004

Kronos Bio Inc (KRON)

Overview News Price History Option Chain Financials Discussions Forecast

Kronos Bio Inc stock is traded at $1.024, with a volume of 1,337. It is up +0.39% in the last 24 hours and up +3.41% over the past month. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Previous Close:

$1.02

Open:

$1.03

24h Volume:

1,337

Relative Volume:

0.00

Market Cap:

$61.55M

Revenue:

Net Income/Loss:

$-112.67M

P/E Ratio:

-0.5251

EPS:

-1.95

Net Cash Flow:

$-79.26M

1W Performance:

+0.39%

1M Performance:

+3.41%

6M Performance:

+1.39%

1Y Performance:

-2.48%

1-Day Range:

$1.02

$1.03

1-Week Range:

$0.9696

$1.04

52-Week Range:

$0.69

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name

Kronos Bio Inc

Sector

Healthcare (1174)

Industry

Biotechnology (677)

Phone

(650) 781-5200

Address

1300 S. EL CAMINO REAL, SAN MATEO

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

KRON's Discussions on Twitter

Compare KRON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KRON Kronos Bio Inc	1.02	61.55M	0	-112.67M	-79.26M	-1.95
VRTX Vertex Pharmaceuticals Inc	480.77	123.34B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	696.62	76.09B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	648.37	39.34B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	251.00	32.49B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	116.81	28.26B	3.30B	-501.07M	1.03B	-2.1146

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Downgrade	Piper Sandler	Overweight → Neutral
Nov-14-24	Downgrade	TD Cowen	Buy → Hold
Sep-14-22	Initiated	Berenberg	Buy
Oct-20-21	Resumed	Cowen	Outperform
Jun-24-21	Initiated	H.C. Wainwright	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Goldman	Buy
Nov-03-20	Initiated	Jefferies	Buy
Nov-03-20	Initiated	Piper Sandler	Overweight

View All

Kronos Bio Inc Stock (KRON) Latest News

Feb 17, 2025

Layoff Tracker: Kojin Will Soon Close Its Doors, Affecting 25 Employees - BioSpace

Feb 17, 2025

Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat

Feb 17, 2025

Feb 16, 2025

Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat

Feb 16, 2025

Jan 20, 2025

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Jan 20, 2025

Jan 19, 2025

Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat

Jan 19, 2025

Jan 13, 2025

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 13, 2025

Jan 11, 2025

Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Jan 11, 2025

Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat

Jan 01, 2025

Dec 28, 2024

Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia

Dec 28, 2024

Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE

Dec 03, 2024

Dec 02, 2024

Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston

Dec 02, 2024

Dec 01, 2024